The relationship between the cell cycle and early amplification of duck hepatitis B virus covalently closed circular (CCC) DNA was studied after in vitro infection of fetal hepatocytes. We first showed that embryonic hepatocytes proliferated for at least 6 days after plating and that complete viral replication including CCC DNA amplification occurred in these proliferating cells. Addition of sodium butyrate or aphidicolin reversibly blocked cells in the G1 phase and diminished CCC DNA synthesis, which was restored after drug withdrawal, concomitantly with the entry of cells into S phase. Cell cycle progression of fetal hepatocytes can be triggered by stimulation with epidermal growth factor (EGF), hepatocyte growth factor (HGF), and tumor growth factor ␣ (TGF-␣). CCC DNA synthesis increased with progression to the S phase induced by EGF, HGF, and TGF-␣ alone or in combination. By contrast, tumor growth factor  (TGF-) alone or in combination with EGF inhibited cell proliferation and viral DNA synthesis. By double labeling, viral nucleocapsids were found predominantly in bromodeoxyuridine-positive hepatocytes, indicating that high viral replication occurs preferentially in proliferating hepatocytes. CCC DNA was also detected mainly in cells in the S and G2/M phases separated from cells in the G1 phase by cell sorting. Taken Hepatitis B Virus (HBV) is the prototype member of the Hepadnaviridae family that also includes duck hepatitis B virus (DHBV). They are small (3.2 kb) enveloped DNA viruses that can cause acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The mature virions contain a partially double-stranded relaxed circular (RC) DNA molecule that replicates within liver cells via reverse transcription of an RNA intermediate, the pregenome. 1 Transcription of the pregenome occurs in the nucleus of infected cells from a pool of supercoiled covalently closed circular viral DNA (CCC DNA) that is generated by the conversion of RC viral DNA present in nucleocapsids either from (1) virions infecting the cell or (2) the recycling of progeny nucleocapsids formed in the cytoplasm. 2 These two pathways culminate in the formation of a regulated steady-state population of CCC DNA, vital for the replication of the viral genome and the production of all viral proteins. In the absence of stable viral integration, amplification of CCC DNA during in vitro and in vivo infection represents a key event in the viral cycle by which the hepadnaviruses can establish and maintain a persistent infection without cytopathic effects.Recent studies on the treatment of chronic hepadnaviral infections of both humans and ducks with antiviral agents have shown that viral CCC DNA is exceptionally resistant to antiviral treatment strategies 3-5 in the absence of cytokine production or hepatocyte proliferation. The design of specific antivirals will be enhanced by greater knowledge of the events that regulate CCC DNA production. Mutational analyses have established that the DHBV pre-S envelope protein regulates CCC DNA ampli...